NL300249I1 - Cefalosporinen en homologen, bereidingen en farmaceutische preparaten. - Google Patents

Cefalosporinen en homologen, bereidingen en farmaceutische preparaten.

Info

Publication number
NL300249I1
NL300249I1 NL300249C NL300249C NL300249I1 NL 300249 I1 NL300249 I1 NL 300249I1 NL 300249 C NL300249 C NL 300249C NL 300249 C NL300249 C NL 300249C NL 300249 I1 NL300249 I1 NL 300249I1
Authority
NL
Netherlands
Prior art keywords
preparations
cephalosporins
homologues
pharmaceutical
pharmaceutical preparations
Prior art date
Application number
NL300249C
Other languages
English (en)
Other versions
NL300249I2 (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NL300249I1 publication Critical patent/NL300249I1/nl
Publication of NL300249I2 publication Critical patent/NL300249I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL300249C 1990-07-24 2006-11-27 Cefalosporinen en homologen, bereidingen en farmaceutische preparaten. NL300249I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds
PCT/GB1991/001228 WO1992001696A1 (en) 1990-07-24 1991-07-22 Cephalosporins and homologues, preparations and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NL300249I1 true NL300249I1 (nl) 2007-02-01
NL300249I2 NL300249I2 (nl) 2007-02-01

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300249C NL300249I2 (nl) 1990-07-24 2006-11-27 Cefalosporinen en homologen, bereidingen en farmaceutische preparaten.

Country Status (26)

Country Link
EP (2) EP0540606A1 (nl)
JP (2) JPH05509089A (nl)
KR (1) KR100189075B1 (nl)
CN (2) CN1061046C (nl)
AP (1) AP832A (nl)
AT (1) ATE185567T1 (nl)
AU (1) AU648329B2 (nl)
CA (2) CA2359744C (nl)
CZ (1) CZ6493A3 (nl)
DE (2) DE122006000065I2 (nl)
DK (1) DK0540609T3 (nl)
ES (1) ES2137162T3 (nl)
FI (1) FI930270A (nl)
GR (1) GR3031711T3 (nl)
HU (1) HUT63628A (nl)
IE (1) IE912569A1 (nl)
IL (1) IL98909A0 (nl)
LU (1) LU91290I2 (nl)
MX (1) MX9100317A (nl)
MY (1) MY106399A (nl)
NL (1) NL300249I2 (nl)
NO (1) NO930226L (nl)
NZ (1) NZ239061A (nl)
PT (1) PT98426A (nl)
WO (2) WO1992001695A1 (nl)
YU (1) YU129691A (nl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
AU3264393A (en) * 1992-01-22 1993-09-01 Smithkline Beecham Plc 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
WO1998014421A1 (fr) * 1996-10-02 1998-04-09 Daiichi Pharmaceutical Co., Ltd. Procede d'esterification de composes carboxyliques
FR2776292B1 (fr) * 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
ATE319719T1 (de) * 2000-12-04 2006-03-15 Pfizer Prod Inc Verfahren und esterderivate zur herstellung von cephalosphorinen
AU2394302A (en) * 2000-12-04 2002-06-18 Pfizer Prod Inc Coupling process and intermediates useful for preparing cephalosphorins
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
US9073960B2 (en) 2011-12-22 2015-07-07 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
EP2861611B1 (en) 2012-05-25 2016-07-13 Janssen Sciences Ireland UC Uracyl spirooxetane nucleosides
WO2014100505A1 (en) 2012-12-21 2014-06-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
BR112021003156A2 (pt) 2018-08-23 2021-05-11 Seagen, Inc. composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit.
AR120680A1 (es) 2019-12-06 2022-03-09 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio
TW202245800A (zh) 2020-02-18 2022-12-01 美商基利科學股份有限公司 抗病毒化合物
CN118598916A (zh) 2020-02-18 2024-09-06 吉利德科学公司 抗病毒化合物
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
CN114213433B (zh) * 2020-06-08 2023-03-24 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物的制备方法
US11697666B2 (en) 2021-04-16 2023-07-11 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
AR126073A1 (es) 2021-06-04 2023-09-06 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio
CA3228162A1 (en) 2021-08-18 2023-02-23 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
NL7305936A (nl) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
NO930226L (no) 1993-03-23
AU648329B2 (en) 1994-04-21
WO1992001695A1 (en) 1992-02-06
CA2087967A1 (en) 1992-01-25
DE122006000065I1 (de) 2007-03-01
CA2359744C (en) 2007-02-13
CA2359744A1 (en) 1992-02-06
CN1223859A (zh) 1999-07-28
CN1111410C (zh) 2003-06-18
AP9100305A0 (en) 1991-07-31
AP832A (en) 2000-05-03
JP2851428B2 (ja) 1999-01-27
JPH05509089A (ja) 1993-12-16
AU8222491A (en) 1992-02-18
MX9100317A (es) 1992-02-28
CN1061046C (zh) 2001-01-24
LU91290I2 (fr) 2007-01-22
HUT63628A (en) 1993-09-28
NO930226D0 (no) 1993-01-22
JPH05509305A (ja) 1993-12-22
NL300249I2 (nl) 2007-02-01
KR100189075B1 (ko) 1999-06-01
KR930701456A (ko) 1993-06-11
HU9300177D0 (en) 1993-04-28
MY106399A (en) 1995-05-30
PT98426A (pt) 1992-05-29
IE912569A1 (en) 1992-01-29
FI930270A (fi) 1993-03-22
GR3031711T3 (en) 2000-02-29
IL98909A0 (en) 1992-07-15
EP0540609B1 (en) 1999-10-13
FI930270A0 (fi) 1993-01-22
YU129691A (sh) 1994-01-20
CN1060469A (zh) 1992-04-22
EP0540609A1 (en) 1993-05-12
DE69131714D1 (de) 1999-11-18
WO1992001696A1 (en) 1992-02-06
ATE185567T1 (de) 1999-10-15
DK0540609T3 (da) 1999-12-27
CA2087967C (en) 2002-09-10
DE122006000065I2 (de) 2007-09-13
ES2137162T3 (es) 1999-12-16
CZ6493A3 (en) 1994-04-13
NZ239061A (en) 1993-11-25
DE69131714T2 (de) 2000-02-24
EP0540606A1 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
NL300249I1 (nl) Cefalosporinen en homologen, bereidingen en farmaceutische preparaten.
FI915826A0 (fi) Farmaceutiska aemnen.
NO902658D0 (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
DE69018647D1 (de) Arzneimittel.
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
DE68910833D1 (de) Polylactid-zubereitungen.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
NO912799L (no) Foradditiver for droevtyggere.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
FI900035A0 (fi) Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
NO890453D0 (no) Artropodicide preparater.
DE58906751D1 (de) Pigmentzubereitungen.
NO874193D0 (no) Farmasoeytiske preparater.
FI923371A0 (fi) En farmaceutisk formulation.
DE59004652D1 (de) Pigmentpräparationen.
DE68910125D1 (de) Oral-Präparate.
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
ZA915725B (en) Cephalosporins and homologues,preparations and pharmaceutical compositions
FI900814A0 (fi) Farmaceutisk aktiva foereningar.
ATE86094T1 (de) Kosmetisches praeparat.
ATE97318T1 (de) Polylactid-zubereitungen.
FR2666089B1 (fr) Bis-cyclotriveratrylenes, leurs preparations et leurs applications.